Literature DB >> 6096449

Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.

J Grabbe, B M Czarnetzki, T Rosenbach, M Mardin.   

Abstract

Skin biopsies and scale extracts from 22 patients with psoriasis were examined for the presence of chemotactic lipoxygenase products of arachidonate metabolism. Heat-stable leukocyte chemotactic activity in aqueous extracts of 2-mm punch biopsies from involved and uninvolved patient skin was significantly elevated, compared to healed psoriatic skin and to skin of normal controls. Ether extracts (pH 3.0) from 13 mg of psoriatic scales contained a mean chemotactic activity corresponding to that of leukotriene B4, 5 X 10(-8) M. On reverse phase high-pressure liquid chromatography, the main chemotactic lipids in scale extracts were leukotriene B4 and 5-HETE. Since lipoxygenase products are potent mediators of inflammation, they may play an important role in the evolution and maintenance of psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096449     DOI: 10.1111/1523-1747.ep12260985

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients.

Authors:  J Solá; L Vila; L Puig; J M de Moragas
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Differential effects of nylon fibre adherence on the production of superoxide anion by human polymorphonuclear neutrophilic granulocytes stimulated with chemoattractants, ionophore A23187 and phorbol myristate acetate.

Authors:  E Kownatzki; S Uhrich
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

3.  The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation.

Authors:  D Aked; S J Foster; A Howarth; M E McCormick; H C Potts
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

4.  Leukocyte chemotactic properties of soluble horny contents in epidermal cysts.

Authors:  H Takematsu; T Terui; W Torinuki; H Tagami
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.

Authors:  N Ohmi; C Tani; K Yamada; M Fukui
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

6.  Cytochrome P-450-dependent production of chemotactic arachidonate metabolites from human neutrophils.

Authors:  B M Czarnetzki; G Goerz; K Bolsen; H Merk
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay.

Authors:  C Brideau; C Van Staden; A Styhler; I W Rodger; C C Chan
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

8.  Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.

Authors:  C Miller; R Y Yamaguchi; V A Ziboh
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

9.  A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile.

Authors:  F Grimminger; P Mayser; C Papavassilis; M Thomas; E Schlotzer; K U Heuer; D Führer; K D Hinsch; D Walmrath; W B Schill
Journal:  Clin Investig       Date:  1993-08

10.  Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

Authors:  E Kownatzki; A Kapp; S Uhrich
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.